Free Trial

Cellebrite DI (CLBT) News Today

$10.65
+0.13 (+1.24%)
(As of 05/31/2024 ET)
Cellebrite DI Ltd. (NASDAQ:CLBT) Receives Average Recommendation of "Buy" from Brokerages
Shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) have been assigned a consensus rating of "Buy" from the six research firms that are covering the firm, Marketbeat reports. Six research analysts have rated the stock with a buy rating. The average 1-year target price among brokerages tha
Cellebrite DI Ltd. (NASDAQ:CLBT) Shares Purchased by Trexquant Investment LP
Trexquant Investment LP boosted its position in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 297.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 261,749 shares of the company's stock after acquiring an additional
Cellebrite DI (NASDAQ:CLBT) PT Raised to $14.00
Cellebrite DI (NASDAQ:CLBT) Stock Price Down 6%
Cellebrite DI (NASDAQ:CLBT) Given New $14.00 Price Target at JPMorgan Chase & Co.
JPMorgan Chase & Co. upped their price target on shares of Cellebrite DI from $12.00 to $14.00 and gave the company an "overweight" rating in a research note on Friday.
Cellebrite DI Ltd. (CLBTW)
Cellebrite DI (NASDAQ:CLBT) Issues Quarterly Earnings Results
Cellebrite DI (NASDAQ:CLBT - Get Free Report) released its quarterly earnings data on Thursday. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of $0.06 by $0.02. The firm had revenue of $89.60 million during the quarter, compared to the consensus estimate of $85.34 million. Cellebrite DI had a positive return on equity of 173.14% and a negative net margin of 24.94%. The firm's quarterly revenue was up 25.8% on a year-over-year basis. During the same period in the previous year, the company posted $0.03 earnings per share.
Cellebrite DI (NASDAQ:CLBT) Stock Price Up 5.3%
Cellebrite DI (NASDAQ:CLBT) Shares Up 5.3%
Cellebrite Announces First-Quarter 2024 Results
Cellebrite Q1 2024 Earnings Preview
IGP Investments G.P.L.P LP Purchases New Holdings in Cellebrite DI Ltd. (NASDAQ:CLBT)
IGP Investments G.P.L.P LP acquired a new position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 21,087,692 shares of the company's
74,834 Shares in Cellebrite DI Ltd. (NASDAQ:CLBT) Purchased by Hsbc Holdings PLC
Hsbc Holdings PLC acquired a new position in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 74,834 shares of the company's stock, valued at appro
Lake Street Capital Begins Coverage on Cellebrite DI (NASDAQ:CLBT)
Lake Street Capital initiated coverage on shares of Cellebrite DI in a report on Friday. They issued a "buy" rating and a $13.00 price target for the company.
Voss Capital LLC Raises Holdings in Cellebrite DI Ltd. (NASDAQ:CLBT)
Voss Capital LLC raised its position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 207.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,835,000 shares of the company's stock after acq
205,021 Shares in Cellebrite DI Ltd. (NASDAQ:CLBT) Bought by Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD acquired a new position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor
Cellebrite DI Ltd. (NASDAQ:CLBT) Short Interest Up 11.5% in March
Cellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) saw a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 2,620,000 shares, an increase of 11.5% from the February 29th total of 2,350,000 shares. Based on an average daily volume of 978,000 shares, the short-interest ratio is presently 2.7 days. Currently, 4.7% of the company's shares are sold short.
Cellebrite DI (NASDAQ:CLBT) Price Target Raised to $16.00 at Craig Hallum
Craig Hallum increased their price target on Cellebrite DI from $14.00 to $16.00 and gave the stock a "buy" rating in a report on Monday.
Cellebrite DI (NASDAQ:CLBT) Price Target Raised to $13.50
Needham & Company LLC raised their price objective on shares of Cellebrite DI from $13.00 to $13.50 and gave the stock a "buy" rating in a report on Thursday.
Cellebrite DI (NASDAQ:CLBT) Shares Down 4.6%
Cellebrite DI (NASDAQ:CLBT) Stock Price Down 4.6%
Cellebrite Files its 2023 Annual Report on Form 20-F
Cellebrite Files its 2023 Annual Report on Form 20-F
Cellebrite DI Target of Unusually Large Options Trading (NASDAQ:CLBT)
Cellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) was the recipient of unusually large options trading on Monday. Stock traders purchased 5,037 call options on the stock. This represents an increase of approximately 3,604% compared to the typical volume of 136 call options.
Cellebrite DI (NASDAQ:CLBT) Shares Gap Up to $11.51
Cellebrite DI (NASDAQ:CLBT) Shares Gap Up to $11.51
Cellebrite DI Ltd. (NASDAQ:CLBT) Given Consensus Rating of "Buy" by Analysts
Cellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) has been given an average rating of "Buy" by the four research firms that are currently covering the firm, MarketBeat Ratings reports. Four research analysts have rated the stock with a buy recommendation. The average 12-month price target among b
Cellebrite DI Ltd. (NASDAQ:CLBT) Shares Sold by Greenhaven Road Investment Management L.P.
Greenhaven Road Investment Management L.P. lessened its stake in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 10.1% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,172,607 shares of the company's stock
Cellebrite DI (NASDAQ:CLBT) Rating Increased to Outperform at William Blair
William Blair raised shares of Cellebrite DI from a "market perform" rating to an "outperform" rating in a report on Wednesday.
UPDATE – Cellebrite Announces 2024 Investor Day
Cellebrite Announces 2024 Investor Day
Get Cellebrite DI News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLBT and its competitors with MarketBeat's FREE daily newsletter.

SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

CLBT Media Mentions By Week

CLBT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CLBT
News Sentiment

0.67

0.72

Average
Business Services
News Sentiment

CLBT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CLBT Articles
This Week

8

3

CLBT Articles
Average Week

Get Cellebrite DI News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLBT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:CLBT) was last updated on 6/1/2024 by MarketBeat.com Staff

From Our Partners